Familial hypercholesterolaemia

access DNA testing wherever they live. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure Evidence of local arrangements to ensure that relatives of people with a confirmed diagnosis of monogenic FH are offered DNA testing through a nationwide systematic cascade process. Data source: Local data collection. Process a) Proportion of untested first-degree relatives of people with a confirmed diagnosis of monogenic FH who are offered cascade testing. Numerator – The number of people in the denominator offered cascade testing. Denominator – The number of untested first-degree relatives of people with a confirmed diagnosis of monogenic FH. Data source: Local data collection using a dedicated database. b) Proportion of at-risk, untested, second- and third-degree relatives of people with a confirmed diagnosis of monogenic FH who are offered cascade testing. Numerator – The number of people in the denominator offered cascade testing. Denominator – The number of at-risk, untested, second- and third-degree relatives of people with a confirmed diagnosis of monogenic FH. Data source: Local data collection using a dedicated database.
